Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > Fusiform keratoplasty shows promising results for treating severe infectious keratitis
  • Cornea and External Disease

Fusiform keratoplasty shows promising results for treating severe infectious keratitis

Kelsey Moroz

Fusiform penetrating keratoplasty (FPK) offers comparable visual outcomes to conventional penetrating keratoplasty (PK) for patients with severe infectious keratitis, while reducing the risk of certain postoperative complications, according to a study.

In the study, 14 eyes underwent FPK using multiple trephines of varying sizes, while 15 eyes received conventional PK. Outcomes measured included best-corrected visual acuity (BCVA), refractive parameters, endothelial cell density, and postoperative complications.

The FPK group, followed for an average of 15.3 months, had similar BCVA outcomes to the PK group after 1 year, with no significant difference in visual acuity. However, FPK demonstrated lower mean curvature, mean astigmatism, and mean spherical equivalent compared to PK. Complications were notably fewer in the FPK group: only one case of peripheral anterior synechia compared to 6 in the PK group. In addition, suture loosening and neovascularization occurred more frequently in the PK group. No cases of graft rejection or increased intraocular pressure were observed in either group.

Reference
Qi XL, Wang LC, Wang ML, Gao H. A surgical alternative of fusiform penetrating keratoplasty for the management of severe infectious keratitis. Int J Ophthalmol. 2024;17(8):1431-1436. doi: 10.18240/ijo.2024.08.07. PMID: 39156785; PMCID: PMC11286445.

Share

Related Content

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

  • Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

  • Conference Roundup

New screening device for keratoconus may help identify patients earlier

  • General

Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon